IHF GmbH is present at the DGK Herztage in Berlin. You will find us at exhibition stand 4 at the foyer of the Maritim Hotel Berlin.Read more
Let our team help you turn your idea into a successful study.
Regardless of how much you have already developed your idea or whether it is still in the initial planning stages, we sit down with you and work together to develop your idea. You contribute your expertise and we use our experience to guide you.
We work together with you to turn your idea into the concept for your study. In collaboration with you, we define the scientific, methodical and statistic requirements for the study protocol and plan a schedule for the study that can be reliably implemented.
We work together to establish criteria for patient safety. We discuss what data is necessary for your study and develop the right case report form for you with our EBogen software. This means that you obtain clear and valid data for your research.
We determine the expected duration of the study according to your requirements. We work with the study centres to establish the realistic number of patients you can expect for your study.
Using the Monte Carlo simulation, we use a number of different possible study scenarios to calculate the number of patients that can be reliably expected over the course of your study on a statistical basis.
You receive a model that illustrates patient inclusion and also takes into account the deviations that can occur in any study.
Budget and financing
We will use your concept as the basis for creating a transparent and viable time and cost schedule that can be used to win over potential donors. If you wish, we would be happy to help you with this.
Submission to ethics committees
Medical Devices Act (MPG) Sections 20-23a
MPG Section 23b
Post Authorisation Safety Study
Federal Institute for Drugs and Medical Devices (BfArM) & Paul Ehrlich Institute (PEI)
Comparative studies of strategies
MPA (Medicinal Products Act)
Federal Office for Radiation Protection (Bundesamt für Strahlenschutz)
"Scramble of data": This was the title Christiane Lober, statistician at IHF GmbH, used to present the database system she developed at the 23rd SAS Users in Research and Development Conference in Berlin.Read more
First patient enrolled in the REBOOT PARADOX clinical trial at Ludwigs-Maximilians-University Munich.Read more